Johnson Financial Group Inc (Wisconsin)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-130
Closed -$9.29K 910
2023
Q4
$9.29K Buy
+130
New +$9.29K ﹤0.01% 663